Dr. Reddy’s Laboratories launches Trientine Hydrochloride Capsules in US market

07 Feb 2020 Evaluate

Dr. Reddy's Laboratories has launched Trientine Hydrochloride Capsules USP, 250 mg, a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the U.S. Food and Drug Administration (USFDA).

The Syprine brand and generic product had U.S. sales or approximately $94.2 million MAT for the most recent twelve months ending in December 2019 according to IMS Health. The company’s Trientine Hydrochloride Capsules USP, 250 mg are available in 100 count bottles. Syprine is a trademark of Alton Pharma.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharm aceuticals in India and overseas.

Dr. Reddys Lab Share Price

1171.15 -4.40 (-0.37%)
19-Jan-2026 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.00
Dr. Reddys Lab 1171.15
Cipla 1397.25
Zydus Lifesciences 880.40
Lupin 2176.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×